undamentalytics Newsletter

Ingevity Corp balance sheet

At the end of fiscal 2025, Ingevity Corp had total assets of $1.65bn, total liabilities of $1.62bn and shareholders' equity of $29.7m. It held $78.1m in cash against $1.21bn of debt: net debt of $1.13bn.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Ingevity Corp: balance sheet, annual
Fiscal year2014Dec 20142015Dec 20152016Dec 20162017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Cash and equivalents2032318878572582757796687897
Receivables—9590100119150148——————
Inventory—149151158191213189241335309196186154
Total current assets—296295369423463629725683659493454544
Goodwill1312121213143644544251952817544
Total assets7177798339301,3152,1422,3352,4692,7372,6232,0231,6511,538
Accounts payable—6579839399104126175158959288
Total current liabilities—100137153183216223269304363264341338
Short-term debt—989112326201846147144
Long-term debt—804814447411,2281,2671,2501,4731,3831,3401,1611,056
Total debt0894924557591,2581,3071,2811,4801,4731,4051,2121,203
Total liabilities—2616986529771,6111,6921,7952,0381,9921,8271,6211,491
Shareholders' equity4175141272783395316426746986311953047
Net debt (negative = net cash)−20574613676811,2011,0491,0051,4031,3771,3371,1341,105
Shares outstanding——42m42m42m42m41m39m37m36m36m35m34m

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: HWKN vs NGVTBCPC vs NGVTALTO vs NGVT

More: Specialty Chemicals stocks compared, Materials sector, rankings of US companies

Figures from Ingevity Corp's SEC filings (10-K and 10-Q), retrieved October 26, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Ingevity Corp.